| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.08 |